Uptake likelihood assessment of oral cholera vaccine capsules: insights from stakeholder consultations in five countries
The stakeholders highlighted that vaccine capsules are desirable for use in the general population as they have the potential to have many advantages over the current practice. However, for children who are not able to swallow the capsule, the currently available liquid oral cholera vaccine may be more desirable. To make an eventual informed decision about whether to recommend use of the vaccine capsule, national stakeholders requested the generation of evidence derived from pilot studies.
Authors
- Dijana Spasenoska (ORCID: https://orcid.org/0000-0003-3640-4405)
- Anna-Léa Kahn (ORCID: https://orcid.org/0000-0001-8565-2814)
- Se‐Eun Park (ORCID: https://orcid.org/0000-0001-6644-3080)
- Julia A. Lynch (ORCID: https://orcid.org/0000-0001-8048-5340)
- Malika Bouhenia
- Naveena Aloysia D’Cor (ORCID: https://orcid.org/0000-0002-2930-9322)
- Jung-Seok Lee (ORCID: https://orcid.org/0000-0002-1038-8948)
Institutions
- International Vaccine Institute (KR)
- Yonsei University (KR)
- World Health Organization (CH)
Publication Details
- Journal
- BMC Public Health
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1186/s12889-025-25073-1
- Primary Topic
- Vibrio bacteria research studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust